TCL Archive Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms April 6, 2012
TCL Archive Two More Treatment Programs Moved To DCT; Rauscher Ponders Fate of Cooperative Groups April 18, 1975
TCL Archive Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation May 9, 2014
TCL Archive NCI Programs: Director Challenges Scientists To Develop Molecular “Fingerprints” Of Tumors December 4, 1998